European Journal of Heart Failure

Advancing knowledge in the field of heart failure management

The European Journal of Heart Failure (EJHF) is dedicated to the advancement of knowledge in the field of heart failure management.

The journal publishes reviews and editorials to improve the understanding, prevention, investigation and treatment of heart failure. Molecular and cellular biology, pathology, physiology, electrophysiology, pharmacology, as well as clinical, social and population sciences all form part of the discipline.

Submit your paper

Access your online journal

ESC Journals top-cited articles

ESC Journals top reviewers

Fast Facts

Editor-in-Chief: Michael Böhm (DE)
Current volume: 27 (year 2025)
Issues per subscription: 12
Impact Factor 2023: 16.9

Editor-in-chief History

Name	Professor John Cleland
Start Date	01/01/1999
End Date	31/12/2004

Name	Professor Karl Swedberg
Start Date	01/01/2005
End Date	31/12/2009

Name	Professor Dirk J. Van Veldhuisen
Start Date	01/01/2010
End Date	31/12/2014

Name	Professor Marco Metra
Start Date	01/01/2015
End Date	31/03/2024

Name	Professor Michael Böhm
Start Date	01/04/2024
End Date

Name	Start Date	End Date
Professor John Cleland	01/01/1999	31/12/2004
Professor Karl Swedberg	01/01/2005	31/12/2009
Professor Dirk J. Van Veldhuisen	01/01/2010	31/12/2014
Professor Marco Metra	01/01/2015	31/03/2024
Professor Michael Böhm	01/04/2024

Member Benefits

HFA Members can benefit from discounted or free online access and a print subscription to the European Journal of Heart Failure.

New: Healthcare professionals practicing in low and lower-middle income countries (World Bank classification) are now eligible for a reduced Membership rate.

Become a member

Subscriptions

Subscribe

Connect with us on X

@ESC_Journals

Updates on latest articles

Receive the table of contents in your mailbox.

Track topics and authors important to you and receive articles in your mailbox.

Sign up

For Authors

Before being published, all manuscripts go through double-blind peer review by experienced international experts.

Most recent articles from EJHF

19 Mar 2025

Guideline‐directed medical therapy in patients with left ventricular assist device: Don't forget the native heart

Author(s): Matteo Pagnesi, Luca Baldetti, Anna Mara Scandroglio

17 Mar 2025

Factors associated with the use of guideline‐directed medical therapy in patients with left ventricular assist device

Author(s): Michel Chedid El Helou, Phoo Pwint Nandar, Larisa G. Tereshchenko, Miriam Jacob, Pavan Bhat, Amanda R. Vest, Sanjeeb Bhattacharya, Eileen Hsich, Patrick Collier, W.H. Wilson Tang, Edward Soltesz, Michael Z. Tong, Randall C. Starling, Trejeeve Martyn

17 Mar 2025

How to handle polypharmacy in heart failure. A clinical consensus statement of the Heart Failure Association of the ESC

Author(s): Davide Stolfo, Massimo Iacoviello, Ovidiu Chioncel, Markus S. Anker, Antoni Bayes‐Genis, Frieder Braunschweig, Antonio Cannata, Seif El Hadidi, Gerasimos Filippatos, Pardeep Jhund, Alexandre Mebazaa, Brenda Moura, Massimo Piepoli, Robin Ray, Arsen D. Ristic, Petar Seferovic, Maggie Simpson, Hadi Skouri, Carlo Gabriele Tocchetti, Sophie Van Linthout, Cristiana Vitale, Maurizio Volterrani, Kalliopi Keramida, Sven Wassmann, Basil S. Lewis, Marco Metra, Giuseppe M.C. Rosano, Gianluigi Savarese

12 Mar 2025

Quality of life in heart failure. The heart of the matter. A scientific statement of the Heart Failure Association and the European Association of Preventive Cardiology of the European Society of Cardiology

Author(s): Maurizio Volterrani, Geza Halasz, Stamatis Adamopoulos, Pier Giuseppe Agostoni, Javed Butler, Andrew J.S. Coats, Alan Cohen‐Solal, Wolfram Doehner, Gerasimos Filippatos, Ewa Jankowska, Carolyn S.P. Lam, Ekaterini Lambrinou, Lars H. Lund, Giuseppe Rosano, Marco Metra, Stefania Paolillo, Pasquale Perrone Filardi, Amina Rakisheva, Gianluigi Savarese, Petar Seferovic, Carlo Gabriele Tocchetti, Massimo Piepoli

Show navigation Hide navigation